BlackRock Investment Management, LLC - EPIRUS BIOPHARMACEUTICALS IN ownership

EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 37 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$8,000
-11.1%
3,0150.0%0.00%
Q4 2015$9,000
-25.0%
3,015
+7.4%
0.00%
Q3 2015$12,000
-25.0%
2,8080.0%0.00%
Q2 2015$16,0002,8080.00%
Other shareholders

There were no reported owners of EPIRUS BIOPHARMACEUTICALS IN in Q1 2016.

NameSharesValueWeighting ↓
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders